(Q35356144)

7 August 2017

1 reference

title

Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms (English)

1 reference

7 August 2017

Katherine Yang

1

1 reference

7 August 2017

B Joseph Guglielmo

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

31 July 2007

1 reference

Annals of Pharmacotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

41

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

1427-1435

1 reference

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Nosocomial pneumonia in the intensive care unit: controversies and dilemmas

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Ventilator-associated pneumonia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Incidence, etiology, and outcome of nosocomial pneumonia in ICU patients requiring percutaneous tracheotomy for mechanical ventilation.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Ventilator-associated pneumonia: does surveillance have a role in its management?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

26 September 2018

1 reference

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

What's new in antibiotic resistance? Focus on beta-lactamases

21 January 2018

1 reference

Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae

21 January 2018

1 reference

Extended-spectrum beta-lactamases (ESbLs): characterization, epidemiology and detection

21 January 2018

1 reference

Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).

21 January 2018

1 reference

Wide geographic spread of diverse acquired AmpC beta-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland.

21 January 2018

1 reference

Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.

21 January 2018

1 reference

Occurrence of newer beta-lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals

21 January 2018

1 reference

21 January 2018

The new beta-lactamases.

1 reference

A functional classification scheme for beta-lactamases and its correlation with molecular structure

21 January 2018

1 reference

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

21 January 2018

1 reference

Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics

21 January 2018

1 reference

Beta-lactamase stability and inhibitory activity of meropenem combined with a potent antibacterial activity

21 January 2018

1 reference

Recent developments in beta lactamases and extended spectrum beta lactamases

21 January 2018

1 reference

High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae

21 January 2018

1 reference

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

21 January 2018

1 reference

The inoculum effect: fact or artifact?

21 January 2018

1 reference

Detection of plasmid-mediated class C beta-lactamases.

21 January 2018

1 reference

Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific S

21 January 2018

1 reference

Detection of beta-lactamase-mediated resistance

21 January 2018

1 reference

Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin

21 January 2018

1 reference

Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy

21 January 2018

1 reference

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

21 January 2018

1 reference

Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

21 January 2018

1 reference

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

21 January 2018

1 reference

First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel.

21 January 2018

1 reference

Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.

21 January 2018

1 reference

Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.

21 January 2018

1 reference

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

21 January 2018

1 reference

Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

21 January 2018

1 reference

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

21 January 2018

1 reference

Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia

21 January 2018

1 reference

Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam against Escherichia coli and Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases: Report from the ARREST Program

21 January 2018

1 reference

Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections.

21 January 2018

1 reference

Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

21 January 2018

1 reference

Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs

21 January 2018

1 reference

In vitro activity of three different antimicrobial agents against ESBL producing Escherichia coli and Klebsiella pneumoniae blood isolates

21 January 2018

1 reference

Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

21 January 2018

1 reference

Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England

21 January 2018

1 reference

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents

21 January 2018

1 reference

The pharmacokinetic and pharmacodynamic profile of tigecycline

21 January 2018

1 reference

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

21 January 2018

1 reference

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

21 January 2018

1 reference

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

21 January 2018

1 reference

Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction

21 January 2018

1 reference

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3194036

Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database

15 November 2018

1 reference

12 December 2020

Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study

1 reference

12 December 2020

The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia

1 reference

12 December 2020

Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia

1 reference

12 December 2020

Identifiers

DOI

10.1345/APH.1K213

1 reference

7 August 2017

1 reference

7 August 2017

1 reference